4519 vs LCLA: Side-by-Side Comparison
Compare Chugai Pharmaceutical Co., Ltd. (4519) and PT Kalbe Farma Tbk (LCLA) side by side: market cap JPY 12.40T vs EUR 2.13B. Financials, growth and model signals on Bullrun.
| Metric | 4519 | LCLA |
|---|---|---|
| Company | Chugai Pharmaceutical Co., Ltd. | PT Kalbe Farma Tbk |
| Country / Exchange | Japan · TSE | Indonesia · F |
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers - General | Drug Manufacturers - General |
| Market cap | JPY 12.40T | EUR 2.13B |
| P/E ratio | 28.6 | — |
| Dividend yield | 1.74% | 2.93% |
| Valuation model | — | — |
| Revenue (latest FY) | JPY 1.26T | — |
| Revenue growth YoY | +7.5% | — |
| Net income | — | — |
| Gross margin | 71.1% | — |
| Diluted EPS | 263.72 | — |